Skip to content
Open access

PADL1NK-005 study design: a phase III trial of fetrastobart vedotin (Fetra-V) vs docetaxel in patients with previously treated tumor PD-L1-positive NSCLC.

Nov 2026 · Future Oncology · pp. 1-12 · 0 citations
Medicine

Abstract

CLINICAL TRIAL REGISTRATION NCT07144280 (https://clinicaltrials.gov/study/NCT07144280).

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.